Theranica Co-Founder, CEO, Alon Ironi heads up a highly experienced, ambitious team that has set a goal to translate their technological and business knowledge in mobile digital solutions to the field of pain therapeutics. 12 to 15% of the World’s population suffers from migraines. Alon shares with us how Theranica, through its FDA approved product Nerivio, offers non-invasive, drug-free, personalized and affordable wearable therapeutic products for the treatment of pain by integrating the latest neuroscience research with notable technological expertise.
Alon Ironi, Co-Founder, CEO, Theranica
You must be logged in to rate.